Key points are not available for this paper at this time.
Design
Review
Stimulation of the renal dopaminergic system and AT2 receptors, along with decreasing reactive oxygen species, may offer new therapeutic approaches for hypertension.
Current therapeutic interventions for hypertension predominantly involve correction of an overactive rennin-angiotensin aldosterone system. Recent evidence suggests that stimulation of the renal dopaminergic system and possibly activation of AT2 receptors, as well as decreasing reactive oxygen species, may provide additional therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
John J Gildea (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: